Shijiazhuang Fourth Pharmaceutical Group Selected for China’s Most Influential List in the Pharmaceutical Industry
Category:
Time:2023-07-05
On July 3, the 15th China Pharmaceutical Industry Development Summit Forum, hosted by the Pharmaceutical Industry Chamber of the All-China Federation of Industry and Commerce, was held in Harbin. During the conference, the “2022–2023 List of China’s Most Influential Companies in the Pharmaceutical Industry” was released. Shijiazhuang Sihua Pharmaceutical Group was honored with two prestigious awards: being named among the Top 100 Chinese Pharmaceutical Manufacturers and recognized as a Pioneer Enterprise in China’s Independent Pharmaceutical Innovation.
On July 3, the 15th China Pharmaceutical Industry Development Summit Forum, hosted by the Pharmaceutical Industry Chamber of the All-China Federation of Industry and Commerce, was held in Harbin. During the conference, the “2022–2023 List of China’s Most Influential Companies in the Pharmaceutical Industry” was released. Shijiazhuang Sihua Pharmaceutical Group was honored with two prestigious awards: Top 100 Chinese Pharmaceutical Manufacturers and Pioneer Enterprise for Independent Innovation in the Chinese Pharmaceutical Industry.
In recent years, Shijiazhuang No.4 Pharmaceutical has seized development opportunities and strengthened its sense of responsibility. Guided by the goal of ensuring smooth dual circulation in both domestic and international markets, the company has accelerated its pace in forward-looking research and the building of scientific and technological innovation capabilities. By leveraging its comparative advantages and forging competitive strengths, it has continuously extended, supplemented, and reinforced industrial chains. The pace of transformation and upgrading has quickened, further optimizing its industrial structure. The company’s development path has shifted from scale-driven growth to innovation-driven growth, presenting a rapid and stable development trend. It has achieved new breakthroughs in overall scale, product structure, and development quality, yielding significant economic and social benefits.
It is reported that the Pharmaceutical Industry Chamber of the All-China Federation of Industry and Commerce launched the “China’s Most Influential List in the Pharmaceutical Industry” selection event in 2014, and has since held it continuously for 10 sessions. This year’s selection, conducted jointly with several well-known domestic media outlets, evaluates companies based on dimensions such as performance indicators, independent innovation capabilities, social responsibility index, and professionalization level. The list is hailed as a leading indicator of China’s pharmaceutical industry development, accurately capturing the overall pulse of the sector and attracting widespread attention from industry enterprises and entrepreneurs. Relying on its robust innovation capabilities, strong brand strength, and outstanding business performance, Shijiazhuang Fourth Pharmaceutical has won numerous honors in this selection event for many consecutive years, playing a positive role as a model and leader in promoting high-quality development within the pharmaceutical industry.
Keywords:
Recommended News
SERVICE HOTLINE
Mobile site
E code
Business license